Why Can’t mTOR Inhibitors Kill Cancer?

News   Oct 06, 2017 | Original story from UT Health San Antonio

 
Why Can’t mTOR Inhibitors Kill Cancer?

Mitochondrial elongation, induced by mTOR-inhibiting drugs, contributes to cell survival. Credit: Facility for Electron Microscopy Research/McGill University Department of Anatomy and Cell Biology.

 
 
 

RELATED ARTICLES

Combining Different Malaria Vaccines Could Reduce Cases by 91%

News

Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies. Experimental vaccines, which independently achieve 48% and 68% reductions in malaria cases, can achieve 91% reduction when combined.

READ MORE

Targeting Epigenetic Proteins to Prevent Breast Cancer

News

Researchers have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study suggests that inhibiting these proteins with drugs could prevent the development of breast cancer in women at high risk of the disease.

READ MORE

Glial-Neuronal Interaction Fundamental for Memory

News

When astrocytes in mice overproduce a protein called ephrin-B1, the ability of the animal to retain memory weakens.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy